FinancialVu

Market News and Views

You are here: Home / Top Stories / : Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences

: Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences

by

Merck’s earnings were also hit by lower sales of its COVID antiviral Lagevrio.